Do analysts rate EXFY or VHC?

Expensify presently has a consensus price target of $3.00, suggesting a potential upside of 19.05%. Given Expensify's stronger consensus rating and higher possible upside, analysts clearly believe Expensify is more favorable than Virnetx. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Expensify 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Virnetx 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, EXFY or VHC?

Virnetx has lower revenue, but higher earnings than Expensify. Expensify is trading at a lower price-to-earnings ratio than Virnetx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Expensify $138.10M 1.44 -$21.39M -$0.17 N/A Virnetx $114K 433.29 -$18.23M -$5.37 N/A

Is EXFY or VHC more profitable?

Virnetx has a net margin of 0.00% compared to Expensify's net margin of -11.31%. Expensify's return on equity of -11.54% beat Virnetx's return on equity. Company Net Margins Return on Equity Return on Assets Expensify -11.31% -11.54% -8.34% Virnetx N/A -92.46% -66.74%

Do analysts rate EGAN or VHC?

eGain currently has a consensus target price of $15.25, suggesting a potential upside of 104.42%. Given eGain's stronger consensus rating and higher probable upside, equities analysts plainly believe eGain is more favorable than Virnetx. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eGain 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Virnetx 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, EGAN or VHC?

eGain has higher revenue and earnings than Virnetx. Virnetx is trading at a lower price-to-earnings ratio than eGain, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio eGain $88.43M 2.32 $32.25M $1.38 5.41 Virnetx $114K 433.29 -$18.23M -$5.37 N/A

Is EGAN or VHC more profitable?

eGain has a net margin of 41.68% compared to Virnetx's net margin of 0.00%. eGain's return on equity of 12.56% beat Virnetx's return on equity. Company Net Margins Return on Equity Return on Assets eGain 41.68% 12.56% 7.48% Virnetx N/A -92.46% -66.74%

Do analysts prefer VHC or ZSQR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Virnetx 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Coeptis Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend PERF or VHC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perfect 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Virnetx 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, PERF or VHC?

Perfect has higher revenue and earnings than Virnetx. Virnetx is trading at a lower price-to-earnings ratio than Perfect, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Perfect $69.15M 2.78 $4.64M $0.06 31.50 Virnetx $114K 433.29 -$18.23M -$5.37 N/A

Is PERF or VHC more profitable?

Perfect has a net margin of 8.13% compared to Virnetx's net margin of 0.00%. Perfect's return on equity of 3.73% beat Virnetx's return on equity. Company Net Margins Return on Equity Return on Assets Perfect 8.13% 3.73% 2.98% Virnetx N/A -92.46% -66.74%

Do analysts recommend VHC or RTB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Virnetx 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 RTB Digital, Inc. Common Stock 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Virnetx (VHC) Competitors

$11.80 -0.32 (-2.64%)

As of 04:00 PM Eastern

Compare

VHC vs. EXFY, EGAN, ZSQR, PERF, and RTB

Should you buy Virnetx stock or one of its competitors? Virnetx's main competitors and comparable companies include Expensify (EXFY), eGain (EGAN), Coeptis Therapeutics (ZSQR), Perfect (PERF), and RTB Digital, Inc. Common Stock (RTB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Virnetx compare to Expensify?

Expensify (NASDAQ:EXFY) and Virnetx (NASDAQ:VHC) are both small-cap technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

Expensify presently has a consensus price target of $3.00, suggesting a potential upside of 19.05%. Given Expensify's stronger consensus rating and higher possible upside, analysts clearly believe Expensify is more favorable than Virnetx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Expensify	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Virnetx	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Expensify has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market. Comparatively, Virnetx has a beta of 2.3, suggesting that its stock price is 130% more volatile than the broader market.

Virnetx has a net margin of 0.00% compared to Expensify's net margin of -11.31%. Expensify's return on equity of -11.54% beat Virnetx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Expensify	-11.31%	-11.54%	-8.34%
Virnetx	N/A	-92.46%	-66.74%

In the previous week, Expensify and Expensify both had 1 articles in the media. Expensify's average media sentiment score of 1.89 beat Virnetx's score of 1.87 indicating that Expensify is being referred to more favorably in the media.

Company	Overall Sentiment
Expensify	Very Positive
Virnetx	Very Positive

Virnetx has lower revenue, but higher earnings than Expensify. Expensify is trading at a lower price-to-earnings ratio than Virnetx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Expensify	$138.10M	1.44	-$21.39M	-$0.17	N/A
Virnetx	$114K	433.29	-$18.23M	-$5.37	N/A

68.4% of Expensify shares are held by institutional investors. Comparatively, 10.4% of Virnetx shares are held by institutional investors. 11.7% of Expensify shares are held by insiders. Comparatively, 15.7% of Virnetx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Expensify beats Virnetx on 9 of the 15 factors compared between the two stocks.

How does Virnetx compare to eGain?

eGain (NASDAQ:EGAN) and Virnetx (NASDAQ:VHC) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

eGain has a net margin of 41.68% compared to Virnetx's net margin of 0.00%. eGain's return on equity of 12.56% beat Virnetx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
eGain	41.68%	12.56%	7.48%
Virnetx	N/A	-92.46%	-66.74%

In the previous week, eGain had 4 more articles in the media than Virnetx. MarketBeat recorded 5 mentions for eGain and 1 mentions for Virnetx. Virnetx's average media sentiment score of 1.87 beat eGain's score of 0.23 indicating that Virnetx is being referred to more favorably in the news media.

Company	Overall Sentiment
eGain	Neutral
Virnetx	Very Positive

eGain has higher revenue and earnings than Virnetx. Virnetx is trading at a lower price-to-earnings ratio than eGain, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
eGain	$88.43M	2.32	$32.25M	$1.38	5.41
Virnetx	$114K	433.29	-$18.23M	-$5.37	N/A

eGain has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, Virnetx has a beta of 2.3, suggesting that its share price is 130% more volatile than the broader market.

53.9% of eGain shares are held by institutional investors. Comparatively, 10.4% of Virnetx shares are held by institutional investors. 38.7% of eGain shares are held by insiders. Comparatively, 15.7% of Virnetx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

eGain currently has a consensus target price of $15.25, suggesting a potential upside of 104.42%. Given eGain's stronger consensus rating and higher probable upside, equities analysts plainly believe eGain is more favorable than Virnetx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
eGain	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Virnetx	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

eGain beats Virnetx on 13 of the 16 factors compared between the two stocks.

How does Virnetx compare to Coeptis Therapeutics?

Virnetx (NASDAQ:VHC) and Coeptis Therapeutics (NASDAQ:ZSQR) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Virnetx has a net margin of 0.00% compared to Coeptis Therapeutics' net margin of -773.72%. Coeptis Therapeutics' return on equity of -49.45% beat Virnetx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Virnetx	N/A	-92.46%	-66.74%
Coeptis Therapeutics	-773.72%	-49.45%	-46.88%

In the previous week, Virnetx and Virnetx both had 1 articles in the media. Coeptis Therapeutics' average media sentiment score of 1.89 beat Virnetx's score of 1.87 indicating that Coeptis Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Virnetx	Very Positive
Coeptis Therapeutics	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Virnetx	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Coeptis Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

10.4% of Virnetx shares are owned by institutional investors. Comparatively, 13.9% of Coeptis Therapeutics shares are owned by institutional investors. 15.7% of Virnetx shares are owned by company insiders. Comparatively, 24.3% of Coeptis Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Coeptis Therapeutics has higher revenue and earnings than Virnetx. Virnetx is trading at a lower price-to-earnings ratio than Coeptis Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Virnetx	$114K	433.29	-$18.23M	-$5.37	N/A
Coeptis Therapeutics	$1.36M	114.96	-$11.92M	-$1.63	N/A

Virnetx has a beta of 2.3, indicating that its share price is 130% more volatile than the broader market. Comparatively, Coeptis Therapeutics has a beta of -0.19, indicating that its share price is 119% less volatile than the broader market.

Summary

Coeptis Therapeutics beats Virnetx on 9 of the 12 factors compared between the two stocks.

How does Virnetx compare to Perfect?

Perfect (NYSE:PERF) and Virnetx (NASDAQ:VHC) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Perfect has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market. Comparatively, Virnetx has a beta of 2.3, suggesting that its stock price is 130% more volatile than the broader market.

Perfect has a net margin of 8.13% compared to Virnetx's net margin of 0.00%. Perfect's return on equity of 3.73% beat Virnetx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perfect	8.13%	3.73%	2.98%
Virnetx	N/A	-92.46%	-66.74%

In the previous week, Perfect had 3 more articles in the media than Virnetx. MarketBeat recorded 4 mentions for Perfect and 1 mentions for Virnetx. Virnetx's average media sentiment score of 1.87 beat Perfect's score of 1.04 indicating that Virnetx is being referred to more favorably in the news media.

Company	Overall Sentiment
Perfect	Positive
Virnetx	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perfect	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Virnetx	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Perfect has higher revenue and earnings than Virnetx. Virnetx is trading at a lower price-to-earnings ratio than Perfect, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perfect	$69.15M	2.78	$4.64M	$0.06	31.50
Virnetx	$114K	433.29	-$18.23M	-$5.37	N/A

10.4% of Virnetx shares are owned by institutional investors. 15.7% of Virnetx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Perfect beats Virnetx on 9 of the 14 factors compared between the two stocks.

How does Virnetx compare to RTB Digital, Inc. Common Stock?

Virnetx (NASDAQ:VHC) and RTB Digital, Inc. Common Stock (NASDAQ:RTB) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Virnetx	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
RTB Digital, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

10.4% of Virnetx shares are owned by institutional investors. Comparatively, 17.4% of RTB Digital, Inc. Common Stock shares are owned by institutional investors. 15.7% of Virnetx shares are owned by insiders. Comparatively, 12.4% of RTB Digital, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Virnetx has a beta of 2.3, suggesting that its share price is 130% more volatile than the broader market. Comparatively, RTB Digital, Inc. Common Stock has a beta of 2.18, suggesting that its share price is 118% more volatile than the broader market.

Virnetx has a net margin of 0.00% compared to RTB Digital, Inc. Common Stock's net margin of -216.56%. Virnetx's return on equity of -92.46% beat RTB Digital, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Virnetx	N/A	-92.46%	-66.74%
RTB Digital, Inc. Common Stock	-216.56%	-342.57%	-101.47%

In the previous week, Virnetx and Virnetx both had 1 articles in the media. RTB Digital, Inc. Common Stock's average media sentiment score of 1.89 beat Virnetx's score of 1.87 indicating that RTB Digital, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
Virnetx	Very Positive
RTB Digital, Inc. Common Stock	Very Positive

RTB Digital, Inc. Common Stock has higher revenue and earnings than Virnetx. Virnetx is trading at a lower price-to-earnings ratio than RTB Digital, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Virnetx	$114K	433.29	-$18.23M	-$5.37	N/A
RTB Digital, Inc. Common Stock	$13.05M	14.46	-$17.53M	-$6.36	N/A

Summary

Virnetx beats RTB Digital, Inc. Common Stock on 7 of the 13 factors compared between the two stocks.

Get Virnetx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VHC vs. The Competition

Export

Metric	Virnetx	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$49.40M	$16.32B	$29.59B	$12.83B
Dividend Yield	N/A	3.41%	2.74%	11.27%
P/E Ratio	-2.20	140.34	76.18	25.51
Price / Sales	433.29	1,278.55	588.10	122.84
Price / Cash	N/A	46.37	48.04	36.03
Price / Book	2.24	8.69	7.85	6.33
Net Income	-$18.23M	$436.23M	$677.18M	$349.45M
7 Day Performance	-4.35%	2.13%	0.85%	-0.09%
1 Month Performance	-9.23%	7.24%	4.27%	4.37%
1 Year Performance	N/A	5.38%	187.10%	14.79%

Virnetx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VHC Virnetx	0.5961 of 5 stars	$11.80 -2.6%	N/A	N/A	$49.40M	$114K	N/A	20	Positive News
EXFY Expensify	2.715 of 5 stars	$2.64 +5.6%	$3.00 +13.6%	+31.6%	$208.39M	$142.10M	N/A	140	Positive News
EGAN eGain	2.1526 of 5 stars	$7.30 +0.6%	$15.25 +108.9%	+17.6%	$200.39M	$88.43M	5.29	690	Upcoming Earnings
ZSQR Coeptis Therapeutics	0.3844 of 5 stars	$3.65 -7.8%	N/A	-71.0%	$193.45M	$1.36M	N/A	2	Positive News High Trading Volume
PERF Perfect	1.7783 of 5 stars	$1.87 +0.3%	N/A	-7.4%	$190.46M	$69.15M	31.09	N/A	Positive News Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VHC) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Virnetx (VHC) Competitors